GetTopicDetailResponse(id=978a113610c8, topicName=R/R LBCL, introduction=R/R LBCL, content=CAR-T HDT/ASCT R/R LBCL, image=null, comments=0, allHits=913, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sun Apr 21 23:35:46 CST 2024, time=2024-04-21, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=489667, tagList=[TagDto(tagId=489667, tagName=R/R LBCL)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2258164, encodeId=05402258164c2, content=<a href='/topic/show?id=206e112102dd' target=_blank style='color:#2F92EE;'>#復(fù)發(fā)/難治性大B細(xì)胞淋巴瘤#</a> <a href='/topic/show?id=978a113610c8' target=_blank style='color:#2F92EE;'>#R/R LBCL#</a>, objectTitle=【Blood Adv】liso-cel治療101例R/R LBCL的真實(shí)世界研究, objectType=article, longId=869364, objectId=8366869364b7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220804/1659580207492_8252897.webp, objectUrl=/article/show_article.do?id=8366869364b7, replyNumber=0, likeNumber=27, createdTime=2025-03-28, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=8366869364b7, moduleTitle=【Blood Adv】liso-cel治療101例R/R LBCL的真實(shí)世界研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8366869364b7)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2214233, encodeId=0dd222142333f, content=<a href='/topic/show?id=31978e07508' target=_blank style='color:#2F92EE;'>#苯達(dá)莫司汀#</a> <a href='/topic/show?id=247743555b6' target=_blank style='color:#2F92EE;'>#大B細(xì)胞淋巴瘤#</a> <a href='/topic/show?id=978a113610c8' target=_blank style='color:#2F92EE;'>#R/R LBCL#</a>, objectTitle=【Hemasphere】苯達(dá)莫司汀作為R/R LBCL CAR-T橋接治療安全有效, objectType=article, longId=833752, objectId=b9a0833e52e2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240710/1720579036530_1608702.png, objectUrl=/article/show_article.do?id=b9a0833e52e2, replyNumber=0, likeNumber=133, createdTime=2024-07-10, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b9a0833e52e2, moduleTitle=【Hemasphere】苯達(dá)莫司汀作為R/R LBCL CAR-T橋接治療安全有效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b9a0833e52e2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2199686, encodeId=8c612199686a2, content=<a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a> <a href='/topic/show?id=f3fc113609db' target=_blank style='color:#2F92EE;'>#HDT/ASCT#</a> <a href='/topic/show?id=978a113610c8' target=_blank style='color:#2F92EE;'>#R/R LBCL#</a>, objectTitle=【JITC】HDT/ASCT聯(lián)合CAR-T治療R/R LBCL再添力證, objectType=article, longId=822260, objectId=bb10822260b2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301009/1696894905510_4754896.jpeg, objectUrl=/article/show_article.do?id=bb10822260b2, replyNumber=0, likeNumber=108, createdTime=2024-04-21, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=bb10822260b2, moduleTitle=【JITC】HDT/ASCT聯(lián)合CAR-T治療R/R LBCL再添力證, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=bb10822260b2)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-04-21發(fā)表于陜西省
